Merck’s Phase 3 KEYNOTE-B96 Trial Achieves Key Milestone in Platinum-Resistant Ovarian Cancer, Demonstrating Survival Benefit in All-Comer Population Merck (NYSE: MRK), known as MSD outside of the United States and…
Pulse Biosciences Grants Inducement Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) Pulse Biosciences, Inc. (Nasdaq: PLSE), a bioelectric medicine company pioneering applications of its proprietary Nanosecond Pulsed Field…
Digitail and CDMV Partner to Streamline Veterinary Operations and Improve Patient Care Across Canada Digitail, the industry’s leading AI-native veterinary practice information management system (PIMS), has announced a strategic integration…
bioAffinity Technologies Restores Nasdaq Compliance, Strengthening Path Toward Long-Term Growth bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company dedicated to advancing early-stage cancer diagnostics, announced that it has successfully…
Adagio Medical Announces Up to $50 Million Private Placement to Advance Cardiac Arrhythmia Therapies Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or the “Company”), a leading innovator in the development…
Music Industry Icons Unite to Celebrate Tom Corson at City of Hope’s Spirit of Life Gala, Raising Funds to Advance Cancer Research, Survivorship Programs, and Integrative Therapies one of the…
TP and UNICEF Renew Partnership to Advance Education and Humanitarian Support Globally TP (formerly Teleperformance), a global leader in enterprise digital solutions, and UNICEF have announced the renewal of their…
SelectQuote Research Reveals Critical Gaps in Medicare Care, Underscoring Need for Personalized Healthcare Solutions OVERLAND PARK, Kan.–(BUSINESS WIRE)–SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and the…
Viatris Expands CNS Portfolio in Japan with Acquisition of Aculys Pharma, Gaining Exclusive Rights to Pitolisant and Spydia® Viatris Inc. (Nasdaq: VTRS), a leading global healthcare company, today announced the…
Transforming Autoimmune and Inflammatory Disease Therapies WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), proudly congratulates Dr. Fred Ramsdell, PhD, co-founder and Chair of the…
Taiho Pharmaceutical Grants Exclusive Rights for PI3Kα Inhibitor Risovalisib (CYH33) to Haihe Biopharma Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Haihe Biopharma Co., Ltd. (“Haihe”) today announced the signing of an…
argenx to Present Comprehensive Immunology Data at 2025 AANEM Annual Meeting and MGFA Scientific Session argenx SE (Euronext & Nasdaq: ARGX), a global immunology company dedicated to improving the lives…